TickerFactsScreenerDevelopers

Lantern Pharma Inc. (LTRN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$201.8K2019: $943.3K2020: $19.70M2021: $71.57M2022: $56.04M2023: $40.91M2024: $21.19M2025: $6.53M$6.53M
2018Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$6.53M-69.2%
2024$21.19M-48.2%
2023$40.91M-27.0%
2022$56.04M-21.7%
2021$71.57M+263.3%
2020$19.70M+1988.3%
2019$943.3K+567.4%
2018-$201.8K—